Press "Enter" to skip to content

Lupin launches generic cancer drug in US

Lupin’s Imatinib Mesylate tablets, 100 mg (base) and 400 mg (base), are generic versions of Novartis Pharmaceuticals Corporation’s Gleevec tablets in the same strengths, it added.

Original source: https://health.economictimes.indiatimes.com/news/pharma/lupin-launches-generic-cancer-drug-in-us/70142361?utm_source=RSS&utm_medium=ETRSS

Also Read:   SPARC gets orphan drug designation from USFDA for novel kinase inhibitor